DIA Biosimilars 2013

Articles Published in 2009

Accounting Errors Cost Parexel in Fourth Quarter, Fiscal Year

Tuesday, August 11, 2009 07:13 AM

Parexel’s fourth-quarter revenue and income took a significant hit due to accounting errors related to the August 2008 acquisition of clinical trials technology company Clinphone, according to the contract research organization’s (CRO’s) financial results released last night.

More... »

Cenduit: Now with Patient Reminders

OmniComm Continues to Acquire, Build EDC Business

Monday, August 10, 2009 07:01 AM

Less than a month after announcing the acquisition of eResearch Technology’s EDC offerings, eClinical provider OmniComm Solutions has acquired another EDC business, and chief operating officer Stephen Johnson says this latest deal won’t be the company’s last.

More... »

CRF Health – eCOA Forum

Charles River Labs Lowers Guidance, Acquires Two Companies

Friday, August 7, 2009 11:47 AM

At the same timeCharles River Laboratories announced the acquisition of two companies, the preclinical contract research organization (CRO) lowered its full-year guidance for 2009.

More... »

Kendle Reports 50% Income Drop, Suspends Guidance for 2009

Thursday, August 6, 2009 08:04 AM

Kendle’s net income was cut almost 50% in the second quarter 2009 with income dropping to $3.2 million, or $0.21 per diluted share, compared with net income of $6.3 million, or $0.42 per diluted share in Q2 2008. Net revenues for the quarter were $107.4 million, down from $127 million during the same period last year.

More... »

BioClinica Profits Fall 50%, Continues to Seek Acquisitions

Wednesday, August 5, 2009 06:58 AM

BioClinica’s revenues and profits continued to fall in the second quarter, with net income sliced by half from the same period in 2008 to $529,000. Diluted earnings per share were $0.04 compared with $0.10 in the second quarter 2008. Revenues for the Newtown, Pa.-based contract research organization (CRO) also dropped 11% to $17.1 million.

More... »

CenterWatch Monthly August 2009

Tuesday, August 4, 2009 08:00 AM

Working at the Global Level in China

More... »

Oracle Finalizes Relsys Acquisition

Monday, August 3, 2009 07:03 AM

Software company Oracle finalized its acquisition of Relsys International, a provider of drug safety and risk management applications, in a deal that Oracle says will extend its leadership in the health sciences industry.

More... »

eResearch Income Falls 63%

Friday, July 31, 2009 10:45 AM

Philadelphia-based eResearch Technology (ERT) reported second quarter financial results after the markets closed Thursday. Included in the results were ERT’s electronic data capture (EDC) operations, which were sold to Omnicomm Systems in June.

More... »

Covance Ups Guidance as Early- and Late-Stage Revenues Improve in Q2

Wednesday, July 29, 2009 08:36 PM

Covance reported an increase in both early- and late-stage drug development revenues for the second quarter of 2009 compared with the first quarter, but early-stage revenues remain significantly lower than the same period last year.

More... »

Phase Forward to Acquire Maaguzi for $11M, Profits Down in Q2

Tuesday, July 28, 2009 03:09 PM

Within days of announcing the pending acquisition of Covance’s interactive voice and web response business, eClinical company Phase Forward announced Monday it has purchased technology company Maaguzi for $11 million cash.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs